Guidelines are official policy of both the ACC and AHA. In an effort to maintain relevance at the point of care for clinicians, the Task Force continues to oversee an ongoing process improvement initiative. As a result, in response to pilot projects, several changes to this guideline will be...
4 Excluding patients with low cerebrovascular risk, the vast majority of patients who have AF benefit from prolonged anticoagulation for stroke prevention.5,6 Current guidelines recommend treatment with anticoagulation in all patients with AF if they have had a prior stroke, and also in patients ...
研究显示,在心力衰竭和心房颤动(AFib)患者中,以控制心律为重点的治疗策略(使用导管消融)和以控制心率为重点的治疗策略(使用药物和/或起搏器)在心力衰竭的任何原因或进展导致的死亡方面没有显著差异。试验很早就停止了,因此,揭示两种治疗方法之间差异的统计能力有限;然而,研究人员说,研究中观察到的趋势表明,患者的心衰...
研究人员一直在努力确定抗血小板或抗凝药物对需要治疗的心脏病(如心房颤动AFib)患者的获益和风险,与不需要抗凝药物的患者相比,这些疾病与TAVR手术无关。 阿哌沙班是一种非维生素K拮抗剂血液稀释剂,在某些AFib患者中,它比维生素K拮抗剂(VKA)如华法林和抗血小板药物有更好的临床疗效。由心血管试验发起和组织网络联盟(...
They are not intended to provide a single correct answer; rather, they encourage clinicians to ask questions and consider important factors as they define treatment plans for their patients. Whenever appropriate, ECDPs seek to provide unified articulation of clinical practice guidelines, appropriate use...
Chair, ACC/AHA Task Force on Clinical Practice Guidelines 1. Introduction The purpose of this document is to update the “2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation” (S1.3-1) (2014 AF Guideline) in areas for which new evidence has emerged since its...